Today, the FDA's Vaccines and Related Biological Products Advisory Committee voted 17 to 4 in support of the FDA granting...
Pfizer, BioNTech Receive FDA Advisory Approval for COVID-19 Vaccine Emergency Use in The US

Today, the FDA's Vaccines and Related Biological Products Advisory Committee voted 17 to 4 in support of the FDA granting...
The global freight industry is planning for an initial 2021 goal of shipping an average of 271 million ultra-cold and cold doses per month as the world expects the approval of COVID-19 vaccines (9 million doses per day)
In a press release today, AstraZeneca reported its AZD1222 vaccine against SARS-CoV-2 is ready to report efficacy levels...
Pfizer announced today the successful conclusion of their mRNA-based BNT162b2 vaccine for SARS-CoV-2 produced in partnership with BioNTech. This news comes shortly after...
Yesterday, Ivanka Trump tweeted the news of 90% efficacy in Pfizer and BioNTech's BNT162 mRNA-based vaccine to combat COVID-19. She then made the bold...
Recently I caught up with one volunteer who recently received an experimental vaccine from Pfizer. 21-year-old Skyler Mener is a Junior at Kutztown University of Pennsylvania majoring in Social Work. In late August...
On the heels of Russia’s questionably early commencement of public production of the COVID-19 vaccine, leading SARS-CoV-2 vaccine manufacturers are quickly approaching the Thanksgiving vaccine moment.
In an annoucement today from Pfizer, the Government of Canada has entered into an agreement with the Pfizer and BioNTech to supply the partnership's BNT162 mRNA-based vaccine to combat COVID-19.